OHSU’s Molecular Genetic Pathology Fellowship has received a grant from NeoGenomics Laboratories that will support fellows for the 2021-22 and 2022-23 academic years in the Knight Cancer Institute’s Knight Diagnostic Laboratories.
Launched in 2002 by the Department of Pathology and Laboratory Medicine, the MGP Fellowship trains physicians with expertise in molecular diagnostics who will become clinical consultants on the applications of molecular pathology to a wide variety of clinical settings – with a primary focus on advanced cancer diagnostics. It was among the first molecular genetic pathology fellowships in the U.S., and competition for slots is highly selective.
Maedeh Mohebnasab, M.D., a recent graduate of the OHSU pathology residency, is the first MGP fellow supported by the NeoGenomics grant.
“The fellowship program is important because it allows us to fulfill our educational vision and train the next generation of molecular pathologists,” said Knight Cancer Institute Director Brian Druker, M.D. “We thank NeoGenomics for recognizing the value in supporting our fellows, and for making this gift as we work together to end cancer as we know it.”
NeoGenomics Laboratories operates a network of cancer-focused testing laboratories in the U.S., Europe and Asia. The company reported revenue of more than $440 million last year.
